Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche's Invirase (saquinavir) expanded access lottery to be managed by Parexel.

Executive Summary

ROCHE INVIRASE (SAQUINAVIR) EXPANDED ACCESS LOTTERY MANAGED BY PAREXEL will register HIV-positive patients to be selected for 2,280 available U.S. slots to receive the protease inhibitor, Hoffmann-La Roche announced June 21. Patients who have failed prior antiviral treatment may be registered by their physicians until 5 p.m. July 21, after which a lottery is to be conducted. Invirase will be shipped free of charge to the lottery selectees in August.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026424

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel